AstraZeneca Partner's Orpathys Secures Renewal on China's Drug Reimbursement List

MT Newswires07:37 ET

AstraZeneca's Breast Cancer Drug Wins State Insurance Coverage in China

MT Newswires03:40 ET

AstraZeneca's Strategic Focus and Clinical Trial Success Bolster Buy Rating

TipRanksNov 27 00:36 ET · Ratings

Failure of AstraZeneca's AZD4041 a Blow for Non-opioid OUD Treatments

Yahoo FinanceNov 26 12:41 ET

Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.

Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.

Zhitong FinanceNov 26 08:38 ET

Astrazeneca (AZN.US) combination therapy Truqap phase 3 trial results are positive.

Astrazeneca (AZN.US) announced today the positive results of the CAPItello-281 Phase 3 clinical trial.

Zhitong FinanceNov 26 01:10 ET